Skip to main content
Premium Trial:

Request an Annual Quote

Two Blades, Monsanto Expand Deal for TAL Code Technologies

NEW YORK (GenomeWeb News) – The Two Blades Foundation and Monsanto today announced an expansion of their agreement to provide Monsanto additional TAL Code technologies.

Details about the expansion of the companies' original deal, including financial terms, were not disclosed. Diana Horvath, chief operating officer for the foundation, said in an e-mail that further details "aren't available at this time."

The TAL Code technology was discovered by researchers at Martin-Luther University in Halle, Germany and is based on novel sequence-specific DNA binding proteins that may be designed for the recognition of almost any sequence of interest. Two Blades has the exclusive rights for commercial use of the technology in plants.

Improvements made by Monsanto to the technology will be granted back to the foundation for its programs in subsistence crops, said Two Blades, which is based in Evanston, Ill., and supports the development of durable disease resistance in crop plants.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.